neuvivo.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php | ||
Meta Tags
| Title | Home - |
| Description | About A potential new treatment for ALS that could help patients who are non-responsive to current About Science Patients Pipeline Team News Press Releases Publications Careers Contact Dedicated to stopping ALS progression Working to transform inflammat |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 209.17.116.160 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
neuvivo.com Valuation
|
US$1,730,305
Last updated: 2022-10-12 16:31:44
neuvivo.com has Semrush global rank of 6,117,018. neuvivo.com has an estimated worth of US$ 1,730,305, based on its estimated Ads revenue. neuvivo.com receives approximately 199,651 unique visitors each day. Its web server is located in United States, with IP address 209.17.116.160. According to SiteAdvisor, neuvivo.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,730,305 |
| Daily Ads Revenue | US$1,598 |
| Monthly Ads Revenue | US$47,917 |
| Yearly Ads Revenue | US$574,994 |
| Daily Unique Visitors | 13,311 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neuvivo.com. | A | 7200 | IP: 209.17.116.160 |
| neuvivo.com. | NS | 7200 | NS Record: ns82.worldnic.com. |
| neuvivo.com. | NS | 7200 | NS Record: ns81.worldnic.com. |
| neuvivo.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| neuvivo.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| neuvivo.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| neuvivo.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| neuvivo.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| neuvivo.com. | TXT | 7200 | TXT Record: v=spf1 include:_spf.google.com include:_spf.salesforce.com ~all |
| neuvivo.com. | TXT | 7200 | TXT Record: google-site-verification=c-i2MyZrNX7hYJ8fWtvVEARmGx3iTOMvszArpYnKdj4 |
| neuvivo.com. | TXT | 7200 | TXT Record: google-site-verification=y2R5AI_NHBOGO92Y_RP3TgzZU-LkvhvGjwlJVhuOACE |
HtmlToTextCheckTime:2022-10-12 16:31:44
| About Science Patients Pipeline Team News Press Releases Publications Careers Contact Dedicated to stopping ALS progression Working to transform inflammatory macrophages to control the progression of motor neuron damage About A potential new treatment for ALS that could help patients who are non-responsive to current therapy options Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We are investigating a patented macrophage-targeted technology , NP001, designed to address chronic inflammation, a key factor in the progressive loss of motor function in ALS. To date, the treatment has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are diligently working to move this compound toward regulatory approval, with the goal of delivering an effective new treatment to reduce the suffering caused by ALS. Science Targeting inflammatory macrophages |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty/1.19.9.1 Date: Fri, 04 Feb 2022 12:28:10 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 232 Connection: keep-alive Location: https://www.neuvivo.com/ X-Webcom-Cache-Status: BYPASS HTTP/2 200 server: openresty/1.19.9.1 date: Fri, 04 Feb 2022 12:28:12 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.4.23 x-cache-handler: cache-enabler-engine strict-transport-security: max-age=31536000 x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: "1; mode=block" referrer-policy: no-referrer-when-downgrade x-webcom-cache-status: BYPASS |
neuvivo.com Whois Information
Domain Name: NEUVIVO.COM Registry Domain ID: 1695921067_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2022-01-05T20:35:06Z Creation Date: 2012-01-08T01:29:25Z Registry Expiry Date: 2026-01-08T01:29:25Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS81.WORLDNIC.COM Name Server: NS82.WORLDNIC.COM DNSSEC: signedDelegation DNSSEC DS Data: 63607 13 4 363C9C1300D7F8846B9D007E168EAD8A59ABAFD8368DE289F352AB254BE858B86E54DF9A0EE1B620D36979A938643740 DNSSEC DS Data: 63607 13 2 8EEE05D000649939EF307EA2598A0FA0114BBEBEF5A3D1B9D2D277F2528A6997 DNSSEC DS Data: 63607 13 1 F203025CDEE235F9FD6416A2B5BBEBE093DB1B58 >>> Last update of whois database: 2022-02-04T07:46:42Z <<< |